|
The courts found that the Friedlanders were conducting a scheme for obtaining money or property through the mail by means of materially false representations.
Among the claims made:
- "Ingestion of Metabolite-2050 will cause significant weight loss without willpower, calorie restricted diets or exercise."
- "Ingestion of Metabolite-2050 prevents foods from being converted into stored fat."
- "An obese person who takes Metabolite-2050 may reasonably expect to lose weight while continuing to eat all he or she wants."
- "Intercal-SX is a powerful, bio-active formula that "neutralizes" excess calories from within your body. Intercal-SX actually absorbs excess fats and carbohydrates after you have eaten them, preventing their further conversion into pockets of unsightly, figure-destroying stored fat."
- "With the exclusive Intercal-SX you will lose all of the weight you want to lose -- automatically. For the serious dieter who needs to lose more than 20 pounds, INTERCAL-SX eliminates any chance for you to fail. There is no chance of failure because INTERCAL-SX does it all-scientifically."
A medical weight loss study had also been reproduced verbatim, substituting the company's product names in place of the (non-identical) substances said study had investigated.
Like Strivectin, Metabolite-2050 was offered with a satisfaction guarantee, however it has already been firmly established in law (if not in the marketplace!) that a promise of a refund if a customer is dissatisfied does not dispel the effect of false advertisement.
Saturday, 1 July 2006
"[Friedlander] alleges that PDK has failed to disclose to consumers that its products are untested and lack FDA approval. Friedlander contends that purchasers have relied on these misrepresentations, and that, consequently, PDK has injured the general consuming public. Friedlander also claims that PDK's alleged misrepresentations have eroded general consumer confidence in weight control products; as a result, PDK's actions have reduced the desirability of his product and thereby injured his business."
And yet:
Matter of Basic Research L.L.C., A.G. Waterhouse L.L.C., Klein-Becker USA L.L.C., Sovage Dermalogic Laboratories L.L.C., BAN L.L.C., Dennis Gay, Daniel B. Mowrey and Mitchell K. Friedlander (The Respondents); Compaint Counsel's Motion for Partial Summary Decision, Docket #9318 (Public Document) submitted by members of the Division of Enforcement, Bureau of Consumer Protection, US Federal Trade Commission (the Complaint Counsel) February 7, 2005 relating to a variety of products made and advertised by Strivectin's makers Basic Research L.L.C., and associated companies and individuals. Download PDF (0.5 mb).
Related Skin Care Information, Products and Expert Discussions
|
2010 | January | February | March | April | May | June | July | August | September | October | November | December
|